Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, June 18, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage radiopharmaceutical company...
Hence then, the article about oncoinvent announces positive final data from phase 1 2a trial of radspherin in patients with colorectal peritoneal metastases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases )
Also on site :
- ‘Giggly Squad,’ ‘Call Her Daddy,’ ‘Good Hang With Amy Poehler’ & More Win at 2026 iHeartPodcast Awards: Full List
- Ukraine-Russia war latest: Zelensky arrives in UK as Starmer government vows ‘not to forget war in Europe’
- Scammer posed as ‘well-known adult film star’ to defraud NFL and NBA players online from behind bars, feds say